The biosimilar industry is more mature than at any prior cliff cycle
Specific nutrition protocols for GLP-1 users In the study, only 51% of participants reported receiving information on how to manage potential side effects and only 20% were referred to an RDN, the GNC research reported, noting the need for more education, resources and multi-disciplinary referrals to better support GLP-1 patients
In response to emerging concerns, the FDA updated the warning labels for these medications in October 2024 to include risks such as pulmonary aspiration, where stomach contents enter the lungs during surgery
They increase oxidative stress, damage cellular structures, and promote the fibrotic changes associated with permanent hair loss
Now, the South African Health Products Regulatory Authority (SAHPRA) is sounding the alarm, warning the public against purchasing GLP-1 weight-loss products illegally marketed online
Their brand identity is built around offering a holistic and supportive program that goes beyond the prescription